Cryolife (CRY) 16.43 $CRY NuVasive Hits 52-Week
Post# of 273249
Posted On: 09/07/2016 3:05:04 AM
Cryolife (CRY) 16.43 $CRY
NuVasive Hits 52-Week High on Solid Q2 & Strategic Tie-Ups
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 2:03PM CDT
Share price of NuVasive Inc (NUVA) rallied to a new 52-week high of $66.82 on Sep 2, closing a tad lower at $66.74.
MASI: 59.54 (-0.36), QDEL: 21.56 (-0.02), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
CryoLife Appoints James McDermid as Chief Human Resources Officer
PR Newswire - Tue Sep 06, 7:34AM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today the appointment of James McDermid to the position of Chief Human Resources Officer, effective immediately. Mr. McDermid joins the company from Medtronic where he was Group Vice President, Human Resources for the Cardiac and Vascular Group. He will report to Pat Mackin, Chairman, President, and Chief Executive Officer.
MDT: 87.17 (-0.15), CRY: 16.43 (+0.20)
55.9% Return Seen to Date on SmarTrend CryoLife Call (CRY)
Comtex SmarTrend(R) - Tue Sep 06, 12:23AM CDT
SmarTrend identified an Uptrend for CryoLife (NYSE:CRY) on February 23rd, 2016 at $10.41. In approximately 7 months, CryoLife has returned 55.91% as of today's recent price of $16.23.
CRY: 16.43 (+0.20)
Shares of CRY Up 48.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 26, 12:55PM CDT
SmarTrend identified an Uptrend for CryoLife (NYSE:CRY) on February 23rd, 2016 at $10.41. In approximately 6 months, CryoLife has returned 48.08% as of today's recent price of $15.42.
CRY: 16.43 (+0.20)
PRA Health Sciences (PRAH) Hits 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:59AM CDT
Share price of PRA Health Sciences (PRAH) rallied to a new 52-week high of $52.72 on Aug 23, eventually closing a tad bit higher at $52.59.
MASI: 59.54 (-0.36), PRAH: 49.62 (-0.76), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
BioTelemetry Forms Partnership with Bloomlife, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
BioTelemetry announced a strategic partnership with Bloom Technologies.
MASI: 59.54 (-0.36), BEAT: 18.31 (-0.51), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
5 Medical Device Stocks to Buy on Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:22AM CDT
We have picked five stocks on solid Zacks Rank.
ISRG: 693.12 (+4.75), BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Merit Medical (MMSI) Now a Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:00AM CDT
On Aug 23, Zacks Investment Research raised Merit Medical Systems Inc. (MMSI) to a Zacks Rank #1 (Strong Buy) on estimate revisions.
HYH: 36.65 (+0.08), MASI: 59.54 (-0.36), CRY: 16.43 (+0.20), MMSI: 24.44 (-0.05)
Inogen One G4 Cleared for Onboard Use, Market Hold Strong
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:17AM CDT
Inogen recently announced that its One G4 received an approval for an exclusive use on commercial flights.
MASI: 59.54 (-0.36), INGN: 58.75 (+0.64), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
BioTelemetry (BEAT) Scales New 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:14AM CDT
Share price of BioTelemetry rallied to a new 52-week high of $21.42 on Aug 18.
BABY: 42.11 (+1.47), BEAT: 18.31 (-0.51), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Healthways: A Strong Buy on Solid Q2, Estimate Revision
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:54AM CDT
On Aug 16, Zacks Investment Research upgraded Healthways, Inc to a Zacks Rank #1 (Strong Buy).
BABY: 42.11 (+1.47), HWAY: 25.34 (+0.38), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Masimo (MASI) Gets CE Mark for Respiration Sensor RAS-45
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:35AM CDT
Masimo recently announced the receipt of CE mark for RAS-45 respiration sensor for "rainbow acoustic monitoring" of respiration rate.
BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Accuray (ARAY) Q4 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:44AM CDT
Shares of Accuray witnessed a 13.2% plunge in after-hours trading following the company???s fourth-quarter fiscal 2016 results.
MASI: 59.54 (-0.36), ARAY: 5.55 (+0.13), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Allscripts' (MDRX) Sunrise Platform Uptake on the Rise
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:47AM CDT
Allscripts Healthcare Solutions recently announced that its Sunrise platform has been selected by The Bahamian Ministry of Health and the Public Hospitals Authority.
BABY: 42.11 (+1.47), MDRX: 12.88 (unch), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Universal Health Buys Medical Center in Nevada, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:04AM CDT
Universal Health Services recently announced the acquisition of Desert View Regional Medical Center of Rural Health Group in Nevada.
MASI: 59.54 (-0.36), UHS: 119.67 (-1.03), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Teleflex Launches Advanced Percutaneous Surgical System
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:45AM CDT
Following the U.S. Food and Drug Administration's clearance, Teleflex Incorporated (TFX) announced the launch of its second generation Percuvance Percutaneous Surgical system.
BABY: 42.11 (+1.47), TFX: 186.55 (+0.96), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
MEDNAX (MD) Acquires Maternal-Fetal Practice in Florida
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 8:54AM CDT
MEDNAX announced the acquisition of a privately held physician group practice- Maternal Fetal Medicine of Southwest Florida.
MASI: 59.54 (-0.36), CRY: 16.43 (+0.20), MD: 66.89 (+0.32), NUVA: 66.44 (-0.30)
CryoLife (CRY) Raised to Strong Buy on Solid Q2 Results
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 1:37PM CDT
On Aug 12, Zacks Investment Research upgraded CryoLife to a Zacks Rank #1 (Strong Buy).
BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Accuray Expands Product Portfolio, Radixact Now CE-Marked
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 10:36AM CDT
Accuray Inc (ARAY) is expanding its product portfolio on the back of regulatory approvals.
BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), ARAY: 5.55 (+0.13), CRY: 16.43 (+0.20)
New Strong Buy Stocks for August 12th
Tirthankar Chakraborty - Zacks Investment Research - Fri Aug 12, 6:53AM CDT
New Strong Buy Stocks for August 12th
BERY: 45.62 (-0.35), DTSI: 34.05 (-0.05), DECK: 61.21 (-1.99), CRY: 16.43 (+0.20), ASTE: 59.23 (+0.36)
NuVasive Hits 52-Week High on Solid Q2 & Strategic Tie-Ups
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 2:03PM CDT
Share price of NuVasive Inc (NUVA) rallied to a new 52-week high of $66.82 on Sep 2, closing a tad lower at $66.74.
MASI: 59.54 (-0.36), QDEL: 21.56 (-0.02), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
CryoLife Appoints James McDermid as Chief Human Resources Officer
PR Newswire - Tue Sep 06, 7:34AM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today the appointment of James McDermid to the position of Chief Human Resources Officer, effective immediately. Mr. McDermid joins the company from Medtronic where he was Group Vice President, Human Resources for the Cardiac and Vascular Group. He will report to Pat Mackin, Chairman, President, and Chief Executive Officer.
MDT: 87.17 (-0.15), CRY: 16.43 (+0.20)
55.9% Return Seen to Date on SmarTrend CryoLife Call (CRY)
Comtex SmarTrend(R) - Tue Sep 06, 12:23AM CDT
SmarTrend identified an Uptrend for CryoLife (NYSE:CRY) on February 23rd, 2016 at $10.41. In approximately 7 months, CryoLife has returned 55.91% as of today's recent price of $16.23.
CRY: 16.43 (+0.20)
Shares of CRY Up 48.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 26, 12:55PM CDT
SmarTrend identified an Uptrend for CryoLife (NYSE:CRY) on February 23rd, 2016 at $10.41. In approximately 6 months, CryoLife has returned 48.08% as of today's recent price of $15.42.
CRY: 16.43 (+0.20)
PRA Health Sciences (PRAH) Hits 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:59AM CDT
Share price of PRA Health Sciences (PRAH) rallied to a new 52-week high of $52.72 on Aug 23, eventually closing a tad bit higher at $52.59.
MASI: 59.54 (-0.36), PRAH: 49.62 (-0.76), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
BioTelemetry Forms Partnership with Bloomlife, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
BioTelemetry announced a strategic partnership with Bloom Technologies.
MASI: 59.54 (-0.36), BEAT: 18.31 (-0.51), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
5 Medical Device Stocks to Buy on Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:22AM CDT
We have picked five stocks on solid Zacks Rank.
ISRG: 693.12 (+4.75), BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Merit Medical (MMSI) Now a Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:00AM CDT
On Aug 23, Zacks Investment Research raised Merit Medical Systems Inc. (MMSI) to a Zacks Rank #1 (Strong Buy) on estimate revisions.
HYH: 36.65 (+0.08), MASI: 59.54 (-0.36), CRY: 16.43 (+0.20), MMSI: 24.44 (-0.05)
Inogen One G4 Cleared for Onboard Use, Market Hold Strong
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:17AM CDT
Inogen recently announced that its One G4 received an approval for an exclusive use on commercial flights.
MASI: 59.54 (-0.36), INGN: 58.75 (+0.64), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
BioTelemetry (BEAT) Scales New 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:14AM CDT
Share price of BioTelemetry rallied to a new 52-week high of $21.42 on Aug 18.
BABY: 42.11 (+1.47), BEAT: 18.31 (-0.51), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Healthways: A Strong Buy on Solid Q2, Estimate Revision
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:54AM CDT
On Aug 16, Zacks Investment Research upgraded Healthways, Inc to a Zacks Rank #1 (Strong Buy).
BABY: 42.11 (+1.47), HWAY: 25.34 (+0.38), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Masimo (MASI) Gets CE Mark for Respiration Sensor RAS-45
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:35AM CDT
Masimo recently announced the receipt of CE mark for RAS-45 respiration sensor for "rainbow acoustic monitoring" of respiration rate.
BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Accuray (ARAY) Q4 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:44AM CDT
Shares of Accuray witnessed a 13.2% plunge in after-hours trading following the company???s fourth-quarter fiscal 2016 results.
MASI: 59.54 (-0.36), ARAY: 5.55 (+0.13), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Allscripts' (MDRX) Sunrise Platform Uptake on the Rise
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:47AM CDT
Allscripts Healthcare Solutions recently announced that its Sunrise platform has been selected by The Bahamian Ministry of Health and the Public Hospitals Authority.
BABY: 42.11 (+1.47), MDRX: 12.88 (unch), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Universal Health Buys Medical Center in Nevada, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:04AM CDT
Universal Health Services recently announced the acquisition of Desert View Regional Medical Center of Rural Health Group in Nevada.
MASI: 59.54 (-0.36), UHS: 119.67 (-1.03), CRY: 16.43 (+0.20), NUVA: 66.44 (-0.30)
Teleflex Launches Advanced Percutaneous Surgical System
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:45AM CDT
Following the U.S. Food and Drug Administration's clearance, Teleflex Incorporated (TFX) announced the launch of its second generation Percuvance Percutaneous Surgical system.
BABY: 42.11 (+1.47), TFX: 186.55 (+0.96), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
MEDNAX (MD) Acquires Maternal-Fetal Practice in Florida
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 8:54AM CDT
MEDNAX announced the acquisition of a privately held physician group practice- Maternal Fetal Medicine of Southwest Florida.
MASI: 59.54 (-0.36), CRY: 16.43 (+0.20), MD: 66.89 (+0.32), NUVA: 66.44 (-0.30)
CryoLife (CRY) Raised to Strong Buy on Solid Q2 Results
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 1:37PM CDT
On Aug 12, Zacks Investment Research upgraded CryoLife to a Zacks Rank #1 (Strong Buy).
BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), IDXX: 113.95 (-0.14), CRY: 16.43 (+0.20)
Accuray Expands Product Portfolio, Radixact Now CE-Marked
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 10:36AM CDT
Accuray Inc (ARAY) is expanding its product portfolio on the back of regulatory approvals.
BABY: 42.11 (+1.47), MASI: 59.54 (-0.36), ARAY: 5.55 (+0.13), CRY: 16.43 (+0.20)
New Strong Buy Stocks for August 12th
Tirthankar Chakraborty - Zacks Investment Research - Fri Aug 12, 6:53AM CDT
New Strong Buy Stocks for August 12th
BERY: 45.62 (-0.35), DTSI: 34.05 (-0.05), DECK: 61.21 (-1.99), CRY: 16.43 (+0.20), ASTE: 59.23 (+0.36)
(0)
(0)Scroll down for more posts ▼